This page shows Friedman Inds (FRD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FRD’s recent operating model combines compressed margins with inventory-heavy growth and a balance sheet carrying more leverage.
Revenue contracted from$547.5M in FY2023 to$444.6M in FY2025, while gross margin compression made the decline more than a volume issue. Gross margin fell from7.9% to0.6% , leaving little room for selling and administrative costs to absorb weaker sales.
Cash conversion reversed: operating cash flow moved from
By FY2026, inventory was
Financial Health Signals
Friedman Inds does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Friedman Inds reported $19.5M in net income in fiscal year 2026. This represents an increase of 221.0% from the prior year.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Cash & Balance Sheet
Friedman Inds held $2.5M in cash as of fiscal year 2026; long-term debt is not reported for that period.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Margins & Returns
Friedman Inds's ROE was 12.9% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 8.3 percentage points from the prior year.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Capital Allocation
None of these metrics is reported for fiscal year 2026.
FRD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $240.0M | N/A | $168.0M+10.2% | $152.4M+13.1% | $134.8M+4.3% | $129.2M+37.4% | $94.1M-11.9% | $106.8M |
| Cost of Revenue | $218.9M | N/A | $164.1M+9.7% | $149.5M+17.0% | $127.7M-41.0% | $216.7M+9664.0% | $2.2M-97.9% | $107.0M |
| Gross Profit | $21.0M | N/A | $3.9M+35.4% | $2.9M-59.1% | $7.0M+108.1% | -$87.4M-195.2% | $91.9M+41106.7% | -$224K |
| SG&A Expenses | $10.8M | N/A | $7.2M+13.7% | $6.3M+15.3% | $5.5M+42.1% | $3.8M-1.3% | $3.9M-1.2% | $3.9M |
| Operating Income | $21.0M | N/A | $3.9M+35.4% | $2.9M-59.1% | $7.0M+20.4% | $5.9M+593.0% | -$1.2M-429.9% | -$224K |
| Interest Expense | $1.2M | N/A | $1.3M+69.5% | $754K+11.2% | $678K-12.1% | $771K+22.0% | $632K-27.3% | $869K |
| Income Tax | $4.2M | N/A | $961K+30.4% | $737K-54.4% | $1.6M+7.6% | $1.5M+475.8% | -$400K-76.2% | -$227K |
| Net Income | $12.8M | N/A | $3.0M+35.8% | $2.2M-55.4% | $5.0M-5.9% | $5.3M+564.0% | -$1.2M-70.7% | -$675K |
| EPS (Diluted) | $1.79 | N/A | $0.43+34.4% | $0.32-54.9% | $0.71-6.6% | $0.76+547.1% | -$0.17-70.0% | -$0.10 |
Not reported in any period shown, so not listed: R&D Expenses.
FRD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $373.4M+10.9% | $336.8M+8.0% | $311.9M+0.2% | $311.3M+42.1% | $219.1M-3.4% | $226.8M+7.9% | $210.3M+0.5% | $209.2M |
| Current Assets | $291.1M+13.3% | $257.0M+11.0% | $231.5M+0.1% | $231.3M+46.5% | $157.9M-5.1% | $166.5M+11.5% | $149.3M+0.8% | $148.0M |
| Cash & Equivalents | $5.0M+105.2% | $2.5M-18.5% | $3.0M-34.5% | $4.6M+118.5% | $2.1M-43.1% | $3.7M+242.9% | $1.1M-56.5% | $2.5M |
| Inventory | $191.1M+10.9% | $172.2M+1.8% | $169.2M+4.7% | $161.6M+56.2% | $103.5M-9.0% | $113.7M-1.5% | $115.4M+9.8% | $105.1M |
| Accounts Receivable | $90.7M+13.1% | $80.2M+43.7% | $55.8M-10.4% | $62.3M+22.8% | $50.7M+6.8% | $47.5M+49.6% | $31.7M-19.9% | $39.6M |
| Total Liabilities | $209.3M+12.9% | $185.3M+9.2% | $169.6M-1.4% | $172.0M+110.3% | $81.8M-13.3% | $94.4M+13.8% | $82.9M+3.1% | $80.4M |
| Current Liabilities | $100.3M+31.7% | $76.1M+18.2% | $64.4M-9.8% | $71.4M+76.3% | $40.5M+5.6% | $38.3M-9.3% | $42.3M+16.3% | $36.4M |
| Total Equity | $164.2M+8.4% | $151.5M+6.5% | $142.2M+2.1% | $139.3M+1.5% | $137.3M+3.7% | $132.4M+4.0% | $127.3M-1.1% | $128.8M |
| Retained Earnings | $132.1M+10.4% | $119.7M+8.1% | $110.7M+2.6% | $108.0M+1.8% | $106.0M+4.7% | $101.3M+5.3% | $96.2M-1.5% | $97.6M |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
FRD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.3M | N/A | -$4.7M-1186.5% | $437K-97.2% | $15.5M+230.9% | -$11.8M-538.4% | $2.7M-75.0% | $10.8M |
| Capital Expenditures | $2.2M | N/A | $1.6M-34.8% | $2.5M+38.0% | $1.8M+86.1% | $957K-16.4% | $1.1M+35.3% | $846K |
| Free Cash Flow | $5.1M | N/A | -$6.3M-214.3% | -$2.0M-114.7% | $13.7M+207.2% | -$12.8M-923.0% | $1.6M-84.4% | $9.9M |
| Investing Cash Flow | -$1.1M | N/A | -$1.6M+96.7% | -$48.1M-2598.4% | -$1.8M-867.9% | -$184K+47.1% | -$348K+81.1% | -$1.8M |
| Financing Cash Flow | -$1.4M | N/A | $4.8M-90.4% | $49.8M+432.6% | -$15.0M-200.3% | $14.9M+507.8% | -$3.7M+65.3% | -$10.5M |
| Dividends Paid | $284K | N/A | $281K-0.7% | $283K+0.4% | $282K+1.1% | $279K0.0% | $279K+0.4% | $278K |
| Share Buybacks | $82K | N/A | $1K0.0% | -$1K-90.0% | $10K | $0-100.0% | $37K+236.4% | $11K |
FRD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.8% | N/A | 2.3%+0.4pp | 1.9%-3.3pp | 5.2%+72.9pp | -67.7%-165.3pp | 97.6%+97.9pp | -0.2% |
| Operating Margin | 8.8% | N/A | 2.3%+0.4pp | 1.9%-3.3pp | 5.2%+0.7pp | 4.5%+5.8pp | -1.3%-1.1pp | -0.2% |
| Net Margin | 5.3% | N/A | 1.8%+0.3pp | 1.5%-2.3pp | 3.7%-0.4pp | 4.1%+5.4pp | -1.2%-0.6pp | -0.6% |
| Return on Equity | 7.8% | N/A | 2.1%+0.5pp | 1.6%-2.1pp | 3.7%-0.4pp | 4.0%+4.9pp | -0.9%-0.4pp | -0.5% |
| Return on Assets | 3.4% | N/A | 1.0%+0.3pp | 0.7%-1.6pp | 2.3%-0.1pp | 2.4%+2.9pp | -0.5%-0.2pp | -0.3% |
| Current Ratio | 2.90-0.5x | 3.38-0.2x | 3.59+0.4x | 3.24-0.7x | 3.90-0.4x | 4.34+0.8x | 3.53-0.5x | 4.07 |
| Debt-to-Equity | 1.27+0.1x | 1.220.0x | 1.190.0x | 1.24+0.6x | 0.60-0.1x | 0.71+0.1x | 0.650.0x | 0.62 |
| FCF Margin | 2.1% | N/A | -3.8%-2.5pp | -1.3%-11.5pp | 10.2%+20.1pp | -9.9%-11.6pp | 1.7%-7.7pp | 9.3% |
Similar Companies
Where Friedman Inds Ranks
Frequently Asked Questions
Is Friedman Inds profitable?
Yes, Friedman Inds (FRD) reported a net income of $19.5M in fiscal year 2026.
What is Friedman Inds's return on equity (ROE)?
Friedman Inds (FRD) has a return on equity of 12.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What are Friedman Inds's total assets?
Friedman Inds (FRD) had $336.8M in total assets as of fiscal year 2026, including both current and long-term assets.
What is Friedman Inds's current ratio?
Friedman Inds (FRD) had a current ratio of 3.38 as of fiscal year 2026, which is generally considered healthy.
What is Friedman Inds's debt-to-equity ratio?
Friedman Inds (FRD) had a debt-to-equity ratio of 1.22 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Friedman Inds's return on assets (ROA)?
Friedman Inds (FRD) had a return on assets of 5.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.